Literature DB >> 31706666

"I am not a statistic" ovarian cancer survivors' views of factors that influenced their long-term survival.

Aliya Alimujiang1, Lilah Khoja1, Ashley Wiensch1, Malcolm C Pike2, Penelope M Webb3, Georgia Chenevix-Trench4, Anne Chase5, Jean Richardson6, Celeste Leigh Pearce7.   

Abstract

OBJECTIVE: Although a high proportion of women with advanced stage ovarian cancer die within five years, approximately 30% will survive longer than this. The factors contributing to exceptional survival are currently poorly understood. The viewpoints of ovarian cancer survivors were qualitatively explored to determine the factors they felt have influenced their exceptional ovarian cancer survival.
METHODS: Four focus groups, one each in Los Angeles (California), Ann Arbor (Michigan), New York (New York) and Edmonton (Alberta, Canada), were conducted with women who had survived at least five years. Physical activity, diet, meditation, prayer, treatment, complementary medicine, and side effects were explored in semi-structured discussions. The audiotaped sessions were transcribed and coded and then analyzed using Dedoose Version 8.0.35, a qualitative analysis software.
RESULTS: Of the 26 women who participated, 23 had advanced stage disease. Three overarching themes emerged: (a) survivors had improved their 'lifestyles', including but not limited to fitness and diet; (b) survivors were able to draw on strong support systems, which included family, friends, support groups, faith communities, and healthcare workers; and (c) survivors had a strong life purpose, which manifested as positivity, taking charge of their lives, and advocating for themselves.
CONCLUSIONS: Long-term survivors have varying experiences with their cancer, but identified lifestyle modification, motivation and persistence, strong life purpose, and strong support systems as key elements in their better survival. These preliminary findings indicate the need for further prospective studies to determine whether meaningful differences exist between short term and long term survivors on these characteristics.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Advanced stage; Long-term survival; Ovarian cancer; Qualitative research; Survival

Mesh:

Year:  2019        PMID: 31706666     DOI: 10.1016/j.ygyno.2019.10.007

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.304


  7 in total

1.  Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer.

Authors:  Yakir Segev; Ofer Lavie; Nili Stein; Walid Saliba; Noah Samuels; Eiman Shalabna; Orit Gressel Raz; Elad Schiff; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2021-01-06       Impact factor: 3.603

Review 2.  Effectiveness of Complementary Therapies in Cancer Patients: A Systematic Review.

Authors:  María Dolores Guerra-Martín; María Sandra Tejedor-Bueno; Matías Correa-Casado
Journal:  Int J Environ Res Public Health       Date:  2021-01-24       Impact factor: 3.390

3.  A qualitative study of life satisfaction after surgery for adult traumatic brachial plexus injury.

Authors:  Christopher J Dy; David M Brogan; Liz Rolf; Wilson Z Ray; Scott W Wolfe; Aimee S James
Journal:  Bone Jt Open       Date:  2021-01-03

4.  Attributions of survival and methods of coping of long-term ovarian cancer survivors: a qualitative study.

Authors:  Dana Ketcher; Susan K Lutgendorf; Susan Leighton; Marianne Matzo; Jeanne Carter; Arjun Peddireddy; Beth Y Karlan; William P Tew; Anil K Sood; Eileen H Shinn
Journal:  BMC Womens Health       Date:  2021-10-28       Impact factor: 2.809

5.  Exploring perceived risk for COVID-19 and its role in protective behavior and COVID-19 vaccine hesitancy: a qualitative study after the first wave.

Authors:  Naomi J Patterson; Valerie A Paz-Soldan; Richard Oberhelman; Lina Moses; Aubrey Madkour; Thomas T Miles
Journal:  BMC Public Health       Date:  2022-03-15       Impact factor: 3.295

6.  Circ TYMP1 Inhibits Carcinogenesis and Cisplatin Resistance in Ovarian Cancer by Reducing Smad2/3 Phosphorylation via a MicroRNA-182A-3p/TGF1B Axis.

Authors:  Yang Rao; Wenwen Zhang; Dan Li; Xiao Li; Yaomei Ma; Pengpeng Qu
Journal:  Contrast Media Mol Imaging       Date:  2022-08-16       Impact factor: 3.009

Review 7.  Neuroimmunology of cancer and associated symptomology.

Authors:  Nicole N Scheff; Jami L Saloman
Journal:  Immunol Cell Biol       Date:  2021-09-12       Impact factor: 5.853

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.